Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. The company is headquartered in Alhambra, California.
| Revenue (TTM) | $3.84B |
| Gross Profit (TTM) | $402.00M |
| EBITDA | $174.91M |
| Operating Margin | 3.53% |
| Return on Equity | 6.90% |
| Return on Assets | 3.76% |
| Revenue/Share (TTM) | $78.21 |
| Book Value | $16.86 |
| Price-to-Book | 2.05 |
| Price-to-Sales (TTM) | 0.47 |
| EV/Revenue | 0.594 |
| EV/EBITDA | 11.98 |
| Quarterly Earnings Growth (YoY) | 110.50% |
| Quarterly Revenue Growth (YoY) | 48.50% |
| Shares Outstanding | $49.60M |
| Float | $38.84M |
| % Insiders | 22.78% |
| % Institutions | 66.77% |
Volatility is currently contracting
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
ALHAMBRA, Calif., Oct. 9, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2026, after the close of the stock market on Thursday, November 5, 2026.
Astrana Health, Inc. (ASTH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
LOS ANGELES--(BUSINESS WIRE)---- $ASTH--ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law.
SAN FRANCISCO--(BUSINESS WIRE)--AWKO Law LLP is investigating a data breach that led to unauthorized access to the sensitive information of individuals affiliated with Astrana Health, Inc.'s subsidiary, Astrana Health Management, Inc. Astrana Health, Inc. is a California-based technology-powered healthcare company that operates as a Management Services Organization (MSO). On September 23, 2026, Astrana Health, Inc. disclosed to the Securities and Exchange Commission (“SEC”) that unauthorized ac.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ASTH and any ticker you trade — then tracks every position and per-strategy win rate.
